1
|
Mariet AS, Duloquin G, Benzenine E, Roussot A, Pommier T, Eicher JC, Baptiste L, Giroud M, Cottin Y, Béjot Y, Quantin C. Impact of the First COVID-19 Wave on French Hospitalizations for Myocardial Infarction and Stroke: A Retrospective Cohort Study. Biomedicines 2022; 10:biomedicines10102501. [PMID: 36289763 PMCID: PMC9598815 DOI: 10.3390/biomedicines10102501] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 09/22/2022] [Accepted: 10/05/2022] [Indexed: 01/09/2023] Open
Abstract
The COVID-19 pandemic modified the management of myocardial infarction (MI) and stroke. We aimed to evaluate the effect of the COVID-19 pandemic on the volume and spatial distribution of hospitalizations for MI and stroke, before, during and after the first nationwide lockdown in France in 2020, compared with 2019. Hospitalization data were extracted from the French National Discharge database. Patient’s characteristics were compared according to COVID-19 status. Changes in hospitalization rates over time were measured using interrupted time series analysis. Possible spatial patterns of over or under-hospitalization rates were investigated using Moran’s indices. We observed a rapid and significant drop in hospitalizations just before the beginning of the lockdown with a nadir at 36.5% for MI and 31.2% for stroke. Hospitalization volumes returned to those seen in 2019 four weeks after the end of the lockdown, except for MI, which rebounded excessively. Older age, male sex, elevated rate of hypertension, diabetes, obesity and mortality characterized COVID-19 patients. There was no evidence of a change in the spatial pattern of over- or under-hospitalization clusters over the three periods. After a steep drop, only MI showed a significant rebound after the first lockdown with no change in the spatial distribution of hospitalizations.
Collapse
Affiliation(s)
- Anne-Sophie Mariet
- Biostatistics and Bioinformatics (DIM), University Hospital of Dijon, 21000 Dijon, France
- Clinical Epidemiology/Clinical Trials Unit, Clinical Investigation Center, University Hospital of Dijon, CIC1432, 21000 Dijon, France
| | - Gauthier Duloquin
- Neurology Department, University Hospital of Dijon, 21000 Dijon, France
- Dijon Stroke Registry (Santé Publique France-Inserm), University of Burgundy, UFBC, 21000 Dijon, France
- EA 7460 (Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases), University of Burgundy, UFBC, 21000 Dijon, France
| | - Eric Benzenine
- Biostatistics and Bioinformatics (DIM), University Hospital of Dijon, 21000 Dijon, France
| | - Adrien Roussot
- Biostatistics and Bioinformatics (DIM), University Hospital of Dijon, 21000 Dijon, France
| | - Thibaut Pommier
- Cardiology Department, University Hospital of Dijon, 21000 Dijon, France
| | | | - Laura Baptiste
- Neurology Department, University Hospital of Dijon, 21000 Dijon, France
- Dijon Stroke Registry (Santé Publique France-Inserm), University of Burgundy, UFBC, 21000 Dijon, France
- EA 7460 (Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases), University of Burgundy, UFBC, 21000 Dijon, France
| | - Maurice Giroud
- Neurology Department, University Hospital of Dijon, 21000 Dijon, France
- Dijon Stroke Registry (Santé Publique France-Inserm), University of Burgundy, UFBC, 21000 Dijon, France
- EA 7460 (Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases), University of Burgundy, UFBC, 21000 Dijon, France
| | - Yves Cottin
- Cardiology Department, University Hospital of Dijon, 21000 Dijon, France
- Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases, University of Burgundy, 21000 Dijon, France
- Registre des Infarctus du Myocarde de Côte d’Or, University Hospital of Dijon, 21000 Dijon, France
| | - Yannick Béjot
- Neurology Department, University Hospital of Dijon, 21000 Dijon, France
- Dijon Stroke Registry (Santé Publique France-Inserm), University of Burgundy, UFBC, 21000 Dijon, France
- EA 7460 (Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases), University of Burgundy, UFBC, 21000 Dijon, France
| | - Catherine Quantin
- Biostatistics and Bioinformatics (DIM), University Hospital of Dijon, 21000 Dijon, France
- Clinical Epidemiology/Clinical Trials Unit, Clinical Investigation Center, University Hospital of Dijon, CIC1432, 21000 Dijon, France
- Université Paris-Saclay, UVSQ, University of Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, 94800 Villejuif, France
- Correspondence: ; Tel.: +33-3-80-29-36-29
| |
Collapse
|
2
|
Park D, Jeong E, Lee SY, Kim M, Hong DY, Kwon HD, Kim MC. Behavioral and Disease-Related Characteristics of Patients with Acute Stroke during the Coronavirus Disease Pandemic. Healthcare (Basel) 2022; 10:healthcare10040604. [PMID: 35455782 PMCID: PMC9026943 DOI: 10.3390/healthcare10040604] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Revised: 03/21/2022] [Accepted: 03/22/2022] [Indexed: 11/16/2022] Open
Abstract
This study aimed to evaluate the behavioral and disease-related characteristics of patients with acute stroke during the Coronavirus disease (COVID-19) pandemic. This retrospective study was conducted using the Korean Stroke Registry database from a single cerebrovascular specialty hospital. We categorized the COVID-19 pandemic (February 2020 to June 2021) into three waves according to the number of COVID-19 cases recorded and the subjective fear index of the general population and matched them with the corresponding pre-COVID-19 (January 2019 to January 2020) periods. The total number of acute stroke hospitalizations during the pre-COVID-19 and COVID-19 periods was 402 and 379, respectively. The number of acute stroke hospitalizations recorded during the regional outbreak of COVID-19 was higher than that recorded during the corresponding pre-COVID-19 period (97 vs. 80). Length of hospital stay was significantly longer during the COVID-19 pandemic than during the pre-COVID-19 period (11.1 and 8.5 days, respectively; p = 0.003). There were no significant differences in the time from onset to hospital arrival, rate of acute intravenous/intra-arterial (IV/IA) treatments, and door-to-IV/IA times between the pre-COVID-19 and COVID-19 periods. This study suggests that specialty hospitals can effectively maintain the quality of healthcare through the management of acute time-dependent diseases, even during pandemics.
Collapse
Affiliation(s)
- Dougho Park
- Department of Rehabilitation Medicine, Pohang Stroke and Spine Hospital, Pohang 37659, Korea;
| | - Eunhwan Jeong
- Department of Neurology, Pohang Stroke and Spine Hospital, Pohang 37659, Korea; (E.J.); (S.Y.L.)
| | - Su Yun Lee
- Department of Neurology, Pohang Stroke and Spine Hospital, Pohang 37659, Korea; (E.J.); (S.Y.L.)
| | - Mansu Kim
- Department of Neurosurgery, Pohang Stroke and Spine Hospital, Pohang 37659, Korea; (M.K.); (D.Y.H.); (H.D.K.)
| | - Dae Young Hong
- Department of Neurosurgery, Pohang Stroke and Spine Hospital, Pohang 37659, Korea; (M.K.); (D.Y.H.); (H.D.K.)
| | - Heum Dai Kwon
- Department of Neurosurgery, Pohang Stroke and Spine Hospital, Pohang 37659, Korea; (M.K.); (D.Y.H.); (H.D.K.)
| | - Mun-Chul Kim
- Department of Neurosurgery, Pohang Stroke and Spine Hospital, Pohang 37659, Korea; (M.K.); (D.Y.H.); (H.D.K.)
- Correspondence:
| |
Collapse
|